Tokyo, June 18 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058142) titled 'Tofogliflozin-mediated Optimization of Fat metabolism, Lean mass, and EXercise capacity' on June 11.
Study Type:
Observational
Primary Sponsor:
Institute - Sapporo Medical University
Condition:
Condition - Type 2 Diabetes Mellitus
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - In patients with type 2 diabetes, we will examine the effects of tofogliflozin on blood levels of amino acids, particularly beta-aminoisobutyric acid (BAIBA), and evaluate its effects on cardiac function, renal function, muscle strength, and body composition. We will also explore the detail...